Benzinga | Oct 26, 2020 09:49AM EDT

H.C. Wainwright Reiterates Buy on Spectrum Pharmaceuticals, Lowers Price Target to $12

H.C. Wainwright analyst Edward White reiterates Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Buy and lowers the price target from $13 to $12.